Skip to main content
. Author manuscript; available in PMC: 2018 Jun 6.
Published in final edited form as: Health Aff (Millwood). 2018 May;37(5):694–701. doi: 10.1377/hlthaff.2017.1624

TABLE 1.

Examples of Precision Medicine Testing in Use Today

Clinical Question: Susceptibility Screening Diagnosis Prognosis Drug Response Monitoring
Cancer Indication: Breast
Colon
Sarcomas
Cervical Cancer of unknown primary
Ovarian Cancer
Breast Cancer Imatinib (CML)
Crizotinib (NSCL)
Tumor recurrence or progression
Test: BRCA1, BRCA2
HNPCC
TP53, PTEN
HPV genotypes Cancer Origin
OVA1®
Oncotype DX (21-gene assay)
MammaPrint (70-gene assay)
HER2/neu, ER, PR
BCR-ABL
EML4-ALK
CTCs
Cardiovascular Disease Indication: CAD Familial
Hypercholesterolemia
1. Long QT Syndrome
2. ACS
3. CAD
ACS 1. Clopidogrel
2. Statins
3. Warfarin
Transplant rejection
Test: 9p21 APOB, LDLR, LDLRAP1, PCSK9 1. KVLQT1, HERG, SCN5A, ANKB, Mink, MiRP1, KCNJ2, CACNA1C, CAV3, SCN4- beta
2. TnI, BNP, CRP
3. CorusCAD®
cTnI 1. CYP2C19
2. SLCO1B1
3. CYP2C9 VKORC1
AlloMap®

ACS = acute coronary syndromes; BNP = brain natriuretic peptide; CAD = coronary artery disease; CRP = C-reactive protein; CTCs = circulating tumor cells; ER = estrogen receptor; HPV = human papillomavirus; LQTS = long QT syndrome; PR = progesterone receptor; TnI = troponin I.